Capital World Investors Boston Scientific Corp Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Boston Scientific Corp stock. As of the latest transaction made, Capital World Investors holds 16,008,085 shares of BSX stock, worth $1.21 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

16,008,085

Previous 9,419,829 69.94%

Holding current value

$1.21 Billion

Previous $545 Million 101.34%

% of portfolio

0.19%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $379 Million - $452 Million	6,588,256 Added 69.94%	16,008,085 $1.1 Billion
Q4 2023 Feb 13, 2024	BUY	$48.64 - $57.81 $322 Million - $383 Million	6,617,360 Added 236.13%	9,419,829 $545 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $141 Million - $153 Million	2,802,469 New	2,802,469 $148 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $163 Million - $187 Million	-4,234,258 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $105 Million - $118 Million	-2,979,976 Reduced 41.31%	4,234,258 $164 Million

Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $1.79 Billion - $2.26 Billion	-53,922,354 Reduced 88.2%	7,214,234 $259 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $800 Million - $981 Million	-23,225,902 Reduced 27.53%	61,136,588 $2.34 Billion
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $109 Million - $141 Million	3,613,589 Added 4.48%	84,362,490 $2.96 Billion
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $697 Million - $1.23 Billion	-26,997,749 Reduced 25.06%	80,748,901 $2.63 Billion
Q4 2019 Feb 18, 2020	SELL	$37.87 - $45.37 $3.85 Million - $4.61 Million	-101,570 Reduced 0.09%	107,746,650 $4.87 Billion
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $278 Million - $299 Million	6,891,200 Added 6.83%	107,848,220 $4.39 Billion
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $138 Million - $169 Million	3,941,867 Added 4.06%	100,957,020 $4.34 Billion
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $96.2 Million - $119 Million	-2,924,019 Reduced 2.93%	97,015,153 $3.72 Billion
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $321 Million - $394 Million	10,101,411 Added 11.24%	99,939,172 $3.53 Billion
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $588 Million - $692 Million	-17,918,061 Reduced 16.63%	89,837,761 $3.46 Billion
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $9.41 Million - $12 Million	350,718 Added 0.33%	107,755,822 $3.52 Billion
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $168 Million - $191 Million	6,678,286 Added 6.63%	107,405,104 $2.93 Billion
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $7.02 Million - $8.44 Million	-283,378 Reduced 0.28%	100,726,818 $2.5 Billion
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $2.65 Billion - $2.95 Billion	101,010,196	101,010,196 $2.95 Billion

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Boston Scientific Corp Transaction History